Catherine Cherry

Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat.

HIV-associated sensory neuropathies.

Nucleoside analogues and neuropathy in the era of HAART.

Nucleoside analogues and HIV: the combined cost to mitochondria.

Assessment of precision and concordance of quantitative mitochondrial DNA assays: a collaborative international quality assurance study.

Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine.

Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudine.

Mitochondrial toxicity of nucleoside analogues: mechanism, monitoring and management.

Evaluation of a clinical screening tool for HIV-associated sensory neuropathies.

Adverse effects of antiretroviral drugs on HIV-1-infected and -uninfected human monocyte-derived macrophages.

Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-infected individuals.

A six-month, supervised, aerobic and resistance exercise program improves self-efficacy in people with human immunodeficiency virus: a randomised controlled trial.

Replication-dependent pathogenicity of attenuated nef-deleted HIV-1 in vivo.

Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk.

Phase 1 single dose studies to optimize the pharmacokinetics of DG17, a novel HIV-protease inhibitor pro-drug, using sodium bicarbonate and ritonavir.

A report on the effect of commencing enfuvirtide on peripheral neuropathy.

Can we predict neuropathy risk before stavudine prescription in a resource-limited setting?

Measuring and monitoring apoptosis and drug toxicity in HIV patients by ligation-mediated polymerase chain reaction.

Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.

Apoptosis: a clinically useful measure of antiretroviral drug toxicity?

The international physical activity questionnaire overestimates moderate and vigorous physical activity in HIV-infected individuals compared with accelerometry.

Ubisol-Aqua: coenzyme Q10 prevents antiretroviral toxic neuropathy in an in vitro model.

Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients.

HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans.

Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials.

Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana.

Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals.

A longitudinal study of the effects of ART on plasma chemokine levels in Malaysian HIV patients.

β-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells.

Analysis of a previously identified "pain-protective" haplotype and individual polymorphisms in the GCH1 gene in Africans with HIV-associated sensory neuropathy: a genetic association study.

HIV-associated sensory neuropathy: risk factors and genetics.

A new way of measuring apoptosis by absolute quantitation of inter-nucleosomally fragmented genomic DNA.

First molecular epidemiology study of Mycobacterium tuberculosis in Kiribati.

Polymorphisms in uncoupling protein genes UCP2 and UCP3 are not associated with HIV-associated sensory neuropathy in African individuals.

Media discourses of low carbon housing: The marginalisation of social and behavioural dimensions within the British broadsheet press.

Painful HIV-associated sensory neuropathy.

Role of TNF block genetic variants in HIV-associated sensory neuropathy in black Southern Africans.

Macrophage migration inhibitory factor: a potential biomarker for cardiovascular disease in persons with HIV?

TNF Block Gene Variants Associate With Pain Intensity in Black Southern Africans With HIV-associated Sensory Neuropathy.

Testicular loss following bacterial epididymo-orchitis: Case report and literature review.

Pharmacological treatment of painful HIV-associated sensory neuropathy.

Choice of valve type and poor ventricular catheter placement: Modifiable factors associated with ventriculoperitoneal shunt failure.

Polymorphisms in CAMKK2 may predict sensory neuropathy in African HIV patients.

Diagnosing and treating HIV-associated sensory neuropathy: a global perspective.

2016: A 'Mitochondria' Odyssey.

Emerging Role and Characterization of Immunometabolism: Relevance to HIV Pathogenesis, Serious Non-AIDS Events, and a Cure.

Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis.